Blog & Actualités

Insights & Actualités Tech

Découvrez nos derniers articles sur le développement web, le design et les technologies digitales qui façonnent l'avenir

Recherche pour : "health"
Effacer les filtres
The specter of AI-enabled bioweapons is a wake-up call for biotech

The specter of AI-enabled bioweapons is a wake-up call for biotech

In recent weeks, leaders of some of the biggest AI companies have warned that the very tech they are developing is dangerous. Last weekend, Anthropic CEO Dario Amodei argued that AI carries serious risk and that progress should be slowed. OpenAI CEO Sam Altman responded on X: “I agree with Dario...

Building the materials foundation for AI

Building the materials foundation for AI

The AI boom is becoming a materials challenge. As AI pushes computing into new territory, the materials behind that infrastructure are becoming just as crucial as the algorithms running on it. Semiconductors and data centers are approaching physical limits around performance, thermal management,...

The Download: AI’s trillion-dollar gamble and OpenAI’s biology data bid

The Download: AI’s trillion-dollar gamble and OpenAI’s biology data bid

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What’s at stake in AI’s trillion-dollar gamble When Jessica Wachter, a finance professor at the University of Pennsylvania, wanted to assess AI’s...

The Download: AI doomers, whistleblowing agents, and de-aged livers

The Download: AI doomers, whistleblowing agents, and de-aged livers

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. The AI industry has taken a doomer turn. What now? AI chiefs Dario Amodei, Sam Altman, Elon Musk, and Demis Hassabis are suddenly all in agreement:...

AI models need more data about biology, and OpenAI is paying to create it

AI models need more data about biology, and OpenAI is paying to create it

Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies,...

What must happen for AI’s trillion-dollar gamble to pay off

What must happen for AI’s trillion-dollar gamble to pay off

When Jessica Wachter, a finance professor at the University of Pennsylvania’s Wharton School, wanted to assess AI’s impact on the economy over the next few years, she faced a long list of business and technical uncertainties. So she started with what she calls a “remarkable fact” that is not in...

Donated livers can be made biologically younger

Donated livers can be made biologically younger

Once an organ is removed from a donor’s body, the clock starts ticking. Surgeons usually flush the organ with a preservative solution, bag it, and put it on ice—where it immediately starts to degrade. The team has a matter of hours to get it into a recipient’s body. There’s another option—one that...

The Download: AI’s real extinction threat and age-reversal tech for eyes

The Download: AI’s real extinction threat and age-reversal tech for eyes

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Roundtables: could AI really kill us all? Employees at the world’s leading AI labs are saying there’s a real possibility that advanced AI...

The Download: biotech’s future and cheaper, cleaner steel

The Download: biotech’s future and cheaper, cleaner steel

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Meet the under-35s shaping the future of biotech Every year, MIT Technology Review puts together our 35 Innovators Under 35, a list of some of the...

Healthcare AI’s next test is integration

Healthcare AI’s next test is integration

The entrance of major AI companies into healthcare is a meaningful and welcome development, accelerating the technical foundation available to the industry. Their models are increasingly capable of processing long clinical records, interpreting complex terminology, comparing documentation against...

Making the AI-powered case for legacy modernization

Making the AI-powered case for legacy modernization

For years, legacy technology has been a problem companies knew they needed to solve, but one they often struggled to tackle. The cost, complexity, and risk of replacing business-critical systems could make modernization feel like a disruption to manage instead of an opportunity to pursue. But with...